Global Search for Next Antibiotic
News Jun 23, 2015
The Community for Open Antimicrobial Drug Discovery (CO-ADD) is a not-for-profit initiative funded by $3.1 million from the Wellcome Trust, and led by researchers at UQ’s Institute for Molecular Bioscience.
The initiative will invite chemists from around the world to submit their compounds for free screening for antimicrobial activity.
Initiative Director Professor Matthew Cooper said antibiotic resistance cost the Australian economy one billion dollars each year.
“We are heading towards a return to the pre-antibiotic era, when even simple infections caused death,” Professor Cooper said.
“Now it is time to act.”
UQ scientists hope to screen more than 50,000 chemical compounds in the next 18 months, at no cost to the providers of the compounds.
“CO-ADD aims to help researchers around the world find new, diverse compounds to combat the superbug crisis,” Professor Cooper said.
“Each year chemists around the world make millions of compounds, most of these are not designed as antibiotic drugs and would not otherwise be screened for antimicrobial activity.
“The next antibiotic could be out there, sitting on someone’s shelf.”
UQ Vice-Chancellor and President Professor Peter Høj said CO-ADD complemented the global campaign to fight antibiotic resistance.
“This support from the Wellcome Trust, the world’s second-largest charity for biomedical research, shows just how important this ground-breaking approach is,” he said.
“Here at UQ, we’re working to find answers to global problems, translating research into practical solutions.”
Health Minister Cameron Dick said that this work being undertaken by the Institute of Molecular Bioscience showed that Queensland could become a centre of international research excellence.
“The whole Smart State agenda set up by previous Labor Governments was always one for the long term, and what we’re seeing now is some of the end results of that concerted push,” he said.
“Queensland needs to diversify its economy, and one of our major strengths is a well-trained and well-educated workforce.
“The institute has been able to attract well-renowned researchers from around the world, and they know that they will have talented people working with them.”
CO-ADD will screen compounds against strains of bacteria and fungi that cause life-threatening infections, with all results made available to the research community.
The UQ-based team will establish the world’s first antimicrobial-focused open access database of chemical compounds to help researchers understand how antibiotics work and what type of compounds to look for.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Nanomedicine and Nanotechnology
Aug 20 - Aug 21, 2018